Follow
Publications: 18 | Followers: 0

_-Mentoring Faculty Development Needs

Publish on Category: Birds 0

PediatricPsychopharmChartsJuly 2011Meg Cary, MD,MPhMickStorck, MD
Summary of …FDA APPROVED MEDICATIONSin child psychiatry(little specific data for FASD)Attention-deficit Hyperactivity DisorderAll amphetamine and methylphenidate formulations (≥6yo)Dexedrine IR (≥3yo)AtomoxetineGuanfacine ERClonidine ERAggressionRisperidone & Aripiprazole for aggression associated with autismMajor DepressionFluoxetine (≥8yo)Escitalopram (≥12yo)Obsessive-Compulsive DisorderSertraline (≥6yo)Fluoxetine (≥7yo)Fluvoxamine (≥8yo)Clomipramine (≥10yo)Bipolar DisorderRisperidone (≥10yo)Aripiprazole (≥10yo)Quetiapine (≥10yo)Lithium (≥12yo)Olanzapine (≥13yo) – acute treatment onlySchizophreniaRisperidone (≥13yo)Aripiprazole (≥13yo)Quetiapine (≥13yo)Olanzapine (≥13yo)
STIMULANTS
Alpha Adrenergic Agents (for autonomichyperarousal
Hypnotics
Selected REFERENCES
AACAP Practice Parameters.FDA.gov.Calles JL Jr. Use of psychotropic medications in children with developmental disabilities.PediatrClinNorth Am. 2008 Oct;55(5):1227-40McClellan JM,WerryJS. Evidence-based treatments in child and adolescent Psychiatry: an inventory. J AmAcadChildAdolescPsychiatry 2003;42(12): 1388–400.McVoyM,FindlingR. Child and adolescent psychopharmacology update.PsychiatrClinNorth Am 2009;32(1):111–33.Treatment for Adolescents With Depression Study (TADS) Team: March J, Silva S, Curry J, et alThe Treatment for Adolescents With Depression Study (TADS): outcomes over 1 year of naturalistic follow-up. Am J Psychiatry. 2009 Oct;166(10):1141-9.Walkup JT, Albano AM, Piacentini J, et al. Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. N Engl J Med. 2008 Dec 25;359(26):2753-66.

0

Embed

Share

Upload

Make amazing presentation for free
_-Mentoring Faculty Development Needs